P&G: Margins under pressure - Views on News from Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks


Login Failure
(Please do not use this option on a public machine)
  Sign Up | Forgot Password?  

P&G: Margins under pressure

Nov 8, 2012

Procter & Gamble Hygiene and Health Care Ltd. has announced its first quarter results for 2012-2013 (1QFY13) (June ending company). The company has reported a 24% YoY growth in sales and a 6% YoY increase in net profits. Here is our analysis of the results.

Performance summary
  • Procter & Gamble Hygiene and Health Care (PGHH) registered a 24% jump in revenues led by 27% growth in feminine hygiene and 18% higher sales in health care.
  • Operating margins remained staid at around 11% on account of steep escalation in other expenses and employee costs.
  • Earnings increased by a tepid 5.8% as in the year-ago quarter there was a write-back in the tax provision.

Financial snapshot
Rs(m) 1QFY12 1QFY13 Change
Income 3,023 3,756 24.3%
Expenditure 2,671 3,328 24.6%
Operating profit (EBDITA) 352 428 21.8%
EBDITA margin (%) 11.6% 11.4%  
Other income 126 281 123.5%
Interest - -  
Depreciation 64 78 20.5%
Profit before tax 413 632 52.9%
Extraordinary inc/(exp) - -  
Tax -15 179  
Profit after tax/(loss) 428 453 5.8%
Net profit margin (%) 14.2% 12.1%  
No. of shares (m)     32
Diluted earnings per share (Rs)*     57
Price to earnings ratio (x)*     43.98
*trailing twelve months

What has driven performance in 1QFY13?
  • PGHH clocked a 24% growth in sales driven by category growth, pricing and initiatives. Its feminine hygiene business grew by 27% backed by category growth, pricing and innovations. The company's market share in feminine hygiene reached 54%. The healthcare sales grew by 18% on the back of strong growth in Vicks Cough Drops and Vicks Action 500.

  • However operating profitability remained flat at 11% on account of steep rise in other expenditure and higher wages. These have more than offset the cost savings arising as a result of controlled cost of goods sold and ad-spends during the quarter.

  • Despite a 21.8% rise in operating profit, the net profit has grown by a slower 5.8%. This was on account of reversal of tax provision to the tune of Rs 15 m in the year-ago quarter as compared to a tax outgo of Rs 179 m in the current quarter. The other incomes earned by PGHH reported a 124% jump aided by forex gain of Rs 40 m and onetime interest income of Rs 100 m on past litigation.

    Cost break-up
    As a % of net sales 1QFY12 1QFY13 Change in basis points
    Total Cost of goods 43.9% 43.4% -46.35
    Staff Cost 5.1% 5.8% 75.84
    Advertising 20.8% 18.2% -256.08
    Other Expenditure 18.6% 21.1% 250.00

What to expect?
Although PGHH has been reaping the benefits of under-penetration in feminine hygiene driving category growth and strong brand equity of the Vicks brand, its profitability has remained depressed.

At a price of Rs. 2490, the stock is trading at 26 times our estimated FY15 earnings. However, at current levels the stock is overvalued and we would advise a SELL.

To Read the Full Story, Subscribe or Sign In
To Read the Full Story, Subscribe or Sign In

India's #1 Trader
Reveals His Secrets

Secret To Increasing Your Trading Profits Today
Get this Special Report,
The Secret to Increasing Your Trading Profits Today, Now!
We will never sell or rent your email id.
Please read our Terms


Jun 11, 2021 (Close)


  • Track your investment in P&G HYGIENE with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks